ReviewMedical2026

Cannabis sativa L. extract modulates UVB-induced oxidative stress and MITF transcriptional suppression in B16-F10 melanoma cell line.

Mahaprom P.; Narasuwan K.; Wiriyakun N.; Ratanachamnong P.; Korprasertthaworn P.; Vachiramon V.; Tanratana P. · BMC complementary medicine and therapies · 2026

Research summary

**Background & Methods** This in vitro study investigated the photoprotective effects of Cannabis sativa L. extract on UVB-induced oxidative stress in B16-F10 melanoma cells. Chemical profiling was conducted using LC-QTOF-MS and FTIR spectroscopy, while biological activities were assessed through cytotoxicity assays (MTT), intracellular ROS generation (DCFDA), gene expression analysis (RT-qPCR for MITF, TYR, TYRP1, TYRP2), and functional melanogenesis assays measuring tyrosinase activity and melanin content. **Key Findings** • The cannabis extract was dominated by neutral cannabinoids, primarily Δ⁹-THC and CBN, and demonstrated moderate free radical scavenging activity in DPPH assays; critically, pre-treatment with the extract significantly reduced UVB-induced intracellular ROS accumulation in melanoma cells. • UVB exposure suppressed MITF (microphthalmia-associated transcription factor) mRNA expression, which was partially restored at higher extract concentrations, while downstream melanogenic genes (TYR, TYRP1, TYRP2) showed minimal changes under experimental conditions. • The extract attenuated UVB-induced tyrosinase activity at the highest concentration tested, though total melanin content was not significantly altered, suggesting selective modulation of melanogenic pathways without acute depigmentation. **Dosage & Administration** Specific concentrations and dosing schedules for clinical application were not reported. The study used varying extract concentrations in cell culture models without defining therapeutic dosing parameters for dermatological use. **Safety & Adverse Effects** No acute adverse effects or toxicity data were reported in this cell-based study. Cytotoxicity assays were performed but results regarding safety thresholds were not detailed in the abstract provided. **Evidence Quality** This is a preliminary in vitro mechanistic study with significant limitations. The findings are restricted to laboratory melanoma cells and do not establish clinical efficacy or safety in human skin. The study lacks in vivo validation, human trials, and standardized extract characterization. While the antioxidant and MITF-modulating effects are biologically plausible, translation to therapeutic photoprotection requires further investigation. The neutral cannabinoid profile suggests potential relevance for dermatological applications, but regulatory and clinical development pathways remain undefined.

Summary generated by DeepWeed from the published abstract. See the original paper for full methods and results.

Journal
BMC complementary medicine and therapies
Year
2026
Study type
Review
Read the original paper (DOI) ↗
Ask how this study fits the wider evidence — across 26,000+ papers.
Ask DeepWeed

More recent cannabis research

This page summarises published research for informational purposes only — it isn't medical advice. Always refer to the original publication for full methods, results and limitations.

← Back to home